Pioneer Group has teamed up with King’s College London to develop 95,000 sq ft of dedicated start-up incubator space for biotech and medtech companies on London’s South Bank.
The space will be split across two sites which are currently empty, to provide wet and dry laboratories, office and co-working space. Pioneer Group will lead the design, development and operation of the facilities.
Glenn Crocker, executive director at Pioneer Group, said: “King’s is recognised internationally for the impact of its research in life sciences and medicine. It has produced some exceptional spin outs in the last few years in the fields of immunology and oncology amongst others.
“We are delighted to be working with King’s to house and help scale their exciting spin out companies. We look forward to working with the wider team at King’s to help make the journey out of academia and into commercial reality as smooth and efficient as possible.”
Professor Richard Trembath, senior vice president for health and life sciences at King’s College London and executive director of King’s Health Partners, added: “We are delighted to welcome Pioneer Group to the South Bank as they have a proven track record of providing specialist spaces where early-stage spin-outs can flourish. This is an important requirement as we enhance Innovation@King’s and an early pillar for the SC1 life sciences innovation district.
“SC1 is a collaboration between the King’s Health Partners, the London Boroughs of Lambeth and Southwark, and the Guy’s and St Thomas’ Foundation, dedicated to creating partnerships between world-class researchers, clinicians and industry to develop innovative and life-changing technologies and therapies for our local and global communities.”
